Research Paper Volume 16, Issue 10 pp 9106—9126
Defining three ferroptosis-based molecular subtypes and developing a prognostic risk model for high-grade serous ovarian cancer
Figure 2. Association of clinicopathologic characteristics among ferroptosis-based subtypes in TCGA-OV cohort. (A–C) Distributions of age, Stage and Grade among the three subtypes. (D) Distributions of differenced, immunoreactive, mesenchymal, and proliferative subtypes among the three subtypes. (E) Alterations of immune subtypes of C1, C2, C3, and C4 in the three subtypes.